SillaJen, Inc. (215600.KQ)

KRW 2565.0

(0.79%)

Total Debt Summary of SillaJen, Inc.

SillaJen, Inc.'s latest annual total debt in 2023 was 9.69 Billion KRW , down -36.27% from previous year.
SillaJen, Inc.'s latest quarterly total debt in 2024 Q2 was 10.15 Billion KRW , up 2.3% from previous quarter.
SillaJen, Inc. reported annual total debt of 15.21 Billion KRW in 2022, down -9.28% from previous year.
SillaJen, Inc. reported annual total debt of 16.77 Billion KRW in 2021, up 16.79% from previous year.
SillaJen, Inc. reported quarterly total debt of 9.92 Billion KRW for 2024 Q1, up 2.35% from previous quarter.
SillaJen, Inc. reported quarterly total debt of 9.69 Billion KRW for 2023 FY, down -36.27% from previous quarter.

Annual Total Debt Chart of SillaJen, Inc. (2023 - 2014)

Historical Annual Total Debt of SillaJen, Inc. (2023 - 2014)

Year	Total Debt	Total Debt Growth
2023	9.69 Billion KRW	-36.27%
2022	15.21 Billion KRW	-9.28%
2021	16.77 Billion KRW	16.79%
2020	14.36 Billion KRW	103.16%
2019	7.06 Billion KRW	197.47%
2018	2.37 Billion KRW	-34.12%
2017	3.6 Billion KRW	-90.59%
2016	38.35 Billion KRW	287.7%
2015	9.89 Billion KRW	-83.97%
2014	61.73 Billion KRW	0.0%

Year	Total Debt	Total Debt Growth
2024 Q2	10.15 Billion KRW	2.3%
2024 Q1	9.92 Billion KRW	2.35%
2023 FY	9.69 Billion KRW	-36.27%
2023 Q3	11.67 Billion KRW	-23.01%
2023 Q1	15.32 Billion KRW	0.72%
2023 Q4	9.69 Billion KRW	-16.97%
2023 Q2	15.16 Billion KRW	-1.02%
2022 Q2	15.01 Billion KRW	-15.67%
2022 Q4	15.21 Billion KRW	0.72%
2022 FY	15.21 Billion KRW	-9.28%
2022 Q3	15.1 Billion KRW	0.58%
2022 Q1	17.8 Billion KRW	6.18%
2021 FY	16.77 Billion KRW	16.79%
2021 Q2	15.47 Billion KRW	4.31%
2021 Q3	16.24 Billion KRW	4.98%
2021 Q4	16.77 Billion KRW	3.26%
2021 Q1	14.83 Billion KRW	8.85%
2020 Q4	13.62 Billion KRW	2.27%
2020 FY	14.36 Billion KRW	103.16%
2020 Q3	13.32 Billion KRW	0.71%
2020 Q2	13.23 Billion KRW	3101.36%
2020 Q1	413.34 Million KRW	-21.26%
2019 FY	7.06 Billion KRW	197.47%
2019 Q4	524.95 Million KRW	-99.15%
2019 Q3	61.86 Billion KRW	3.36%
2019 Q2	59.85 Billion KRW	6.76%
2019 Q1	56.07 Billion KRW	2259.55%
2018 Q4	2.37 Billion KRW	4.75%
2018 Q2	2.9 Billion KRW	-6.16%
2018 Q3	2.26 Billion KRW	-21.97%
2018 Q1	3.09 Billion KRW	-14.11%
2018 FY	2.37 Billion KRW	-34.12%
2017 Q2	27.42 Billion KRW	-29.07%
2017 Q1	38.65 Billion KRW	0.79%
2017 Q4	3.6 Billion KRW	-81.69%
2017 Q3	19.69 Billion KRW	-28.16%
2017 FY	3.6 Billion KRW	-90.59%
2016 Q2	41.5 Billion KRW	32.23%
2016 Q4	38.35 Billion KRW	-1.68%
2016 Q3	39 Billion KRW	-6.01%
2016 Q1	31.38 Billion KRW	217.26%
2016 FY	38.35 Billion KRW	287.7%
2015 Q1	39.43 Billion KRW	-36.12%
2015 Q3	31.08 Billion KRW	-5.68%
2015 Q4	9.89 Billion KRW	-68.18%
2015 Q2	32.96 Billion KRW	-16.41%
2015 FY	9.89 Billion KRW	-83.97%
2014 FY	61.73 Billion KRW	0.0%
2014 Q4	61.73 Billion KRW	0.0%

Peer Total Debt Comparison of SillaJen, Inc.

Name	Total Debt	Total Debt Difference
HLB Co., Ltd.	62.7 Billion KRW	84.536%
iNtRON Biotechnology, Inc.	402.9 Million KRW	-2306.649%
BINEX Co., Ltd.	53.5 Billion KRW	81.878%
Bioneer Corporation	44.63 Billion KRW	78.278%
Anterogen.Co.,Ltd.	9.74 Billion KRW	0.449%
MEDIPOST Co., Ltd.	52.33 Billion KRW	81.473%
CrystalGenomics, Inc.	32 Billion USD	69.701%
Helixmith Co., Ltd	20.22 Billion KRW	52.063%
Chabiotech Co.,Ltd.	449.63 Billion KRW	97.843%
Medy-Tox Inc.	82.83 Billion KRW	88.293%
Peptron, Inc.	9.13 Billion KRW	-6.171%
Amicogen, Inc.	149.59 Billion KRW	93.518%
Genexine, Inc.	67.42 Billion KRW	85.619%
HLB Therapeutics Co.,Ltd.	10.02 Billion KRW	3.25%
LegoChem Biosciences, Inc.	12.64 Billion KRW	23.31%
ALTEOGEN Inc.	83.76 Billion KRW	88.425%
PharmaResearch Co., Ltd.	34.3 Billion KRW	71.735%
JETEMA, Co., Ltd.	130.49 Billion KRW	92.569%
OliX Pharmaceuticals,Inc	39.35 Billion KRW	75.363%
Genomictree Inc.	1.83 Billion KRW	-428.525%
MedPacto, Inc.	8.6 Billion KRW	-12.697%
D&D Pharmatech	8.13 Billion KRW	-19.207%
EASY BIO,Inc.	82.27 Billion KRW	88.215%
GI Innovation, Inc.	3.72 Billion KRW	-160.603%